{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:50:53Z","timestamp":1786989053883,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.exer.2024.110143","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T15:32:15Z","timestamp":1730302335000},"page":"110143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Neuroprotective effect of Sigma-2 modulator CT2074 in a mouse model of ocular hypertension"],"prefix":"10.1016","volume":"249","author":[{"given":"Nina","family":"Donkor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C.","family":"Kiehlbauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Pappenhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary C.","family":"Look","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Autumn B.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Hamby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8522-4112","authenticated-orcid":false,"given":"Denise M.","family":"Inman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2024.110143_bib1","first-page":"771","article-title":"Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve","volume":"13","author":"Anderson","year":"1974","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2024.110143_bib2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3389\/fncel.2019.00426","article-title":"Early-stage ocular hypertension alters retinal ganglion cell synaptic transmission in the visual thalamus","volume":"13","author":"Bhandari","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.exer.2024.110143_bib3","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1523\/JNEUROSCI.4443-07.2008","article-title":"Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma","volume":"28","author":"Buckingham","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exer.2024.110143_bib4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ceca.2008.12.005","article-title":"F281, synthetic agonist of the sigma-2 receptor, induces Ca2+ efflux from the endoplasmic reticulum and mitochondria in SK-N-SH cells","volume":"45","author":"Cassano","year":"2009","journal-title":"Cell Calcium"},{"key":"10.1016\/j.exer.2024.110143_bib5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2147\/OPTH.S15971","article-title":"Novel ocular antihypertensive compounds in clinical trials","volume":"5","author":"Chen","year":"2011","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.exer.2024.110143_bib6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00401-023-02679-6","article-title":"Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer's disease","volume":"147","author":"Colom-Cadena","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.exer.2024.110143_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2010.12.036","article-title":"Neurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms","volume":"176","author":"Crish","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.exer.2024.110143_bib8","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1073\/pnas.0913141107","article-title":"Distal axonopathy with structural persistence in glaucomatous neurodegeneration","volume":"107","author":"Crish","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.exer.2024.110143_bib9","first-page":"179","article-title":"Ocular and systemic factors associated with glaucoma","volume":"16","author":"Dada","year":"2022","journal-title":"J. Curr. Glaucoma Pract."},{"key":"10.1016\/j.exer.2024.110143_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2014.00290","article-title":"Anterograde transport blockade precedes deficits in retrograde transport in the visual projection of the DBA\/2J mouse model of glaucoma","volume":"8","author":"Dengler-Crish","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.exer.2024.110143_bib11","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.3390\/ijms23073935","article-title":"The role of axonal transport in glaucoma","volume":"23","author":"Dias","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2024.110143_bib12","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s12035-019-01783-7","article-title":"BAX-depleted retinal ganglion cells survive and become quiescent following optic nerve damage","volume":"57","author":"Donahue","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.exer.2024.110143_bib50","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1152\/jn.00227.2016","article-title":"Shared and distinct retinal input to the mouse superior colliculus and dorsal lateral geniculate nucleus","volume":"116","author":"Ellis","year":"2016","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.exer.2024.110143_bib13","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2741\/3303","article-title":"Crosstalk signaling between mitochondrial Ca2+ and ROS","volume":"14","author":"Feissner","year":"2009","journal-title":"Front. Biosci."},{"key":"10.1016\/j.exer.2024.110143_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.556175","article-title":"Anterograde axonal transport in neuronal homeostasis and disease","volume":"13","author":"Guillaud","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.exer.2024.110143_bib15","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005579","article-title":"Apoptosis and autophagy: decoding calcium signals that mediate life or death","volume":"2","author":"Harr","year":"2010","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.exer.2024.110143_bib16","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival","volume":"131","author":"Hayashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.exer.2024.110143_bib17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1208\/s12248-020-00472-x","article-title":"Discovery of a highly selective sigma-2 receptor ligand, 1-(4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-3-methyl-1H-benzo[d]imidazole-2(3H)-one (CM398), with drug-like properties and antinociceptive effects in vivo","volume":"22","author":"Intagliata","year":"2020","journal-title":"AAPS J."},{"key":"10.1016\/j.exer.2024.110143_bib18","article-title":"Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits","volume":"9","author":"Izzo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2024.110143_bib19","article-title":"Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: sigma-2\/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity","volume":"9","author":"Izzo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2024.110143_bib20","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/alz.12302","article-title":"Preclinical and clinical biomarker studies of CT1812: a novel approach to Alzheimer's disease modification","volume":"17","author":"Izzo","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.exer.2024.110143_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/iovs.18-24977","article-title":"Evidence of hypoxic glial cells in a mouse model of ocular hypertension","volume":"6","author":"Jassim","year":"2019","journal-title":"Invest. Ophthal. Vis. Sci."},{"key":"10.1016\/j.exer.2024.110143_bib21","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3390\/antiox11050888","article-title":"Ocular hypertension results in hypoxia within glia and neurons throughout the visual projection","volume":"11","author":"Jassim","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.exer.2024.110143_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48054-y","article-title":"Towards A microbead occlusion model of glaucoma for a non-human primate","volume":"9","author":"Lambert","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2024.110143_bib23","first-page":"17","article-title":"Sigma-1R protects retinal ganglion cells in optic nerve crush model for glaucoma","volume":"62","author":"Li","year":"2021","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2024.110143_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.0010004","article-title":"Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage","volume":"1","author":"Libby","year":"2005","journal-title":"PLoS Genet."},{"key":"10.1016\/j.exer.2024.110143_bib25","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/jnr.24782","article-title":"Sigma-2 receptor antagonists rescue neuronal dysfunction induced by Parkinson's patient brain-derived \u03b1-synuclein","volume":"99","author":"Limegrover","year":"2021","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.exer.2024.110143_bib26","article-title":"Factors associated with delayed first ophthalmological consultation for primary glaucoma: a qualitative interview study","volume":"10","author":"Liu","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.exer.2024.110143_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106575","article-title":"An interim exploratory proteomics biomarker analysis of a phase 2 clinical trial to assess the impact of CT1812 in Alzheimer's disease","volume":"199","author":"Lizama","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.exer.2024.110143_bib28","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.3390\/ijms24076251","article-title":"Sigma-2 receptors\u2014from basic biology to therapeutic target: a focus on age-related degenerative diseases","volume":"24","author":"Lizama","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2024.110143_bib29","first-page":"3182","article-title":"Sigma-2 receptor modulators rescue POS trafficking deficits in RPE cell-based models of dry AMD","volume":"63","author":"Malagise","year":"2022","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2024.110143_bib30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41420-022-01111-4","article-title":"BclXL (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury","volume":"8","author":"Marola","year":"2022","journal-title":"Cell Death Discovery"},{"key":"10.1016\/j.exer.2024.110143_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.exer.2012.11.002","article-title":"Sigma-1 receptor stimulation attenuates calcium influx through activated L-type Voltage Gated Calcium Channels in purified retinal ganglion cells","volume":"107","author":"Mueller","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2024.110143_bib32","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1007\/s43440-021-00310-7","article-title":"Sigma receptors and neurological disorders","volume":"73","author":"Piechal","year":"2021","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.exer.2024.110143_bib33","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/archopht.1979.01020010269018","article-title":"Blockade of rapid axonal transport: effect of intraocular pressure elevation in primate optic nerve","volume":"97","author":"Quigley","year":"1979","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2024.110143_bib34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13024-021-00459-y","article-title":"Neuroprotection by Wld(S) depends on retinal ganglion cell type and age in glaucoma","volume":"16","author":"Risner","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.exer.2024.110143_bib35","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1021\/acschemneuro.7b00200","article-title":"Sigma 2 receptor\/tmem97 agonists produce long lasting antineuropathic pain effects in mice","volume":"8","author":"Sahn","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.exer.2024.110143_bib36","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/s41386-018-0067-z","article-title":"Small molecule modulators of \u03c32R\/Tmem97 reduce alcohol withdrawal-induced behaviors","volume":"43","author":"Scott","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.exer.2024.110143_bib37","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.4103\/jfmpc.jfmpc_111_20","article-title":"Glaucoma blindness-A rapidly emerging non-communicable ocular disease in India: addressing the issue with advocacy","volume":"9","author":"Senjam","year":"2020","journal-title":"J. Fam. Med. Prim. Care"},{"key":"10.1016\/j.exer.2024.110143_bib38","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201900540","article-title":"BRD2 regulation of sigma-2 receptor upon cholesterol deprivation","volume":"4","author":"Shen","year":"2021","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.exer.2024.110143_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.07.002","article-title":"Axon injury signaling and compartmentalized injury response in glaucoma","volume":"73","author":"Syc-Mazurek","year":"2019","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2024.110143_bib40","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.3390\/ijms24076381","article-title":"Sigma-2 receptor ligand binding modulates association between TSPO and TMEM97","volume":"24","author":"Thejer","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2024.110143_bib41","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1021\/acschemneuro.8b00543","article-title":"Neuroprotective efficacy of a sigma 2 receptor\/TMEM97 modulator (DKR-1677) after traumatic brain injury","volume":"10","author":"V\u00e1zquez-Rosa","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.exer.2024.110143_bib48","first-page":"900","article-title":"Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells","volume":"292","author":"Vilner","year":"2000","journal-title":"J Pharmacol. Exp. Ther."},{"key":"10.1016\/j.exer.2024.110143_bib43","article-title":"\u03c3(2)R\/TMEM97 in retinal ganglion cell degeneration","volume":"12","author":"Wang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2024.110143_bib44","series-title":"Functional Study of the AMD-Associated Gene TMEM97 in Retinal Pigmented Epithelium Using CRISPR Interference","author":"Wang","year":"2020"},{"key":"10.1016\/j.exer.2024.110143_bib45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/jnc.13917","article-title":"Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease","volume":"140","author":"Yi","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.exer.2024.110143_bib46","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.3390\/cancers12071877","article-title":"The biological function of sigma-2 receptor\/TMEM97 and its utility in PET imaging studies in cancer","volume":"12","author":"Zeng","year":"2020","journal-title":"Cancers"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483524003658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483524003658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T17:23:43Z","timestamp":1732814623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483524003658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":48,"alternative-id":["S0014483524003658"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2024.110143","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective effect of Sigma-2 modulator CT2074 in a mouse model of ocular hypertension","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2024.110143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110143"}}